Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, June 5, 2013

Gene Variant in Blacks Alters Warfarin Response

I'm sure your doctor will tell you about this before you bring it up to them.
http://www.medpagetoday.com/Cardiology/Strokes/39631?
The first genome-wide association study to focus on warfarin dose in African Americans found a genetic variant that explains their variable response to the blood thinner.
African Americans with one copy of the rs12777823 variant would need to reduce their warfarin dosage by 6.92 mg per week to obtain its full benefits, according to Julie Johnson, PharmD, of the Center for Pharmacogenomics at the University of Florida in Gainesville, and colleagues.
Those of African descent with two copies of this single-nucleotide polymorphism (SNP) would require a dose reduction of about 9 mg/week, a good portion of the 40 mg average weekly dose for African Americans, researchers reported online in The Lancet.

Rest at link.

No comments:

Post a Comment